STATPharmalittle: Merck buys a company for its immunotherapy; Greek parliament debates Novartis bribery caseSTATood morning, everyone, and welcome to the middle of the week. This is, of course, a typically busy time, but today is busier than usual as w… Continue reading
FierceBiotechMedigene gets OK for first trial of T-cell receptor therapyFierceBiotechMedigene gets OK for first trial of T-cell receptor therapy. by Phil Taylor |. Feb 21, 2018 9:25am. Human T cell. Analysts say TCR may have advantages over other techn… Continue reading
Medical XpressFrom blue lights to gene therapy—the intriguing history of Crigler-Najjar syndromeMedical XpressThe clinic is the site of one of the new gene therapy clinical trials. But Crigler-Najjar syndrome was likely here in the US before the Plain … Continue reading
BenzingaSolid Biosciences Snags Bullish Initiation As It Develops Gene Therapy For Muscular DystrophyBenzingaThe young biotech firm Solid Biosciences Inc (NASDAQ: SLDB) secured two Buy ratings Tuesday and another Wednesday. The Rating. Chardan Capital … Continue reading
Down To Earth Magazine (press release) (blog) |
Despite huge cancer burden, India has only 0.4 million blood stem cell donors
Down To Earth Magazine (press release) (blog) Claudia Rutt—who runs one of the oldest blood stem cell donor registries in Germany, DKMS German Bone Marrow Donor Center—says that Germany’s population is more than 82 million and around seven million donors are registered. The similar is the story … |